HyTriage is engages in research, development, production, and sales of in-vitro diagnostic reagents and inspection and analysis instruments.
HyTriage is a Chinese healthcare service company, providing a chronic disease detection and management platform for children and the elderly.HyTriage is engages in research, development, production, and sales of in-vitro diagnostic reagents and inspection and analysis instruments. Through cooperation with a number of in vitro diagnostic research institutions at home and abroad, it has successfully developed colloidal gold immunoassay analyzers, drug detectors, micro-net nebulizers, and lung function training devices.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 15, 2018 | Series B | ¥25M | 1 | Yahui Precision Medicine Fund | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Yahui Precision Medicine Fund | Yes | Series B |